US Emergency Departments Bill Cardiac Observation as Inpatient While Observation Status Denies Coverage

Jul 10, 2026 By Raphael Andriamanjato

Two patients arrive at the same emergency department with chest pain, identical troponin levels, and similar risk profiles. One is admitted as an inpatient, the other placed under observation. Their clinical trajectories may be indistinguishable, but their financial fates diverge sharply. The inpatient patient owes a single hospital deductible, typically around $1,600 for Medicare. The observation patient faces a 20% coinsurance on every service—lab tests, cardiac monitoring, even the aspirin—and, crucially, the days spent under observation do not count toward the three-day inpatient stay required for Medicare to cover a skilled nursing facility stay. This billing distinction, rooted in administrative convenience rather than clinical necessity, has become a quiet driver of financial burden for millions of Americans.

The Same Chest Pain, Two Different Bills

Medicare's observation status was designed for short periods of diagnostic uncertainty—typically less than 24 hours—to decide whether a patient needs inpatient admission. In practice, observation stays have stretched far beyond that. A 2023 analysis by the Medicare Payment Advisory Commission (MedPAC) found that the median observation stay now exceeds 30 hours in many emergency departments, and roughly one in five observation stays lasts longer than 48 hours. Meanwhile, inpatient admissions for chest pain have declined, even as the volume of emergency visits for cardiac symptoms remains stable.

The financial consequences are stark. Under Medicare Part B, observation patients pay 20% of the cost of each service, with no cap. A typical cardiac observation workup—serial troponins, an electrocardiogram, a stress test or coronary computed tomography angiography—can generate bills of $5,000 to $10,000. The patient's share, roughly $1,000 to $2,000, is often more than the inpatient deductible. Private insurers frequently follow Medicare's lead, applying outpatient cost-sharing rules to observation stays. A 2022 study in Health Affairs estimated that observation status cost Medicare beneficiaries an average of $1,200 more per stay than if they had been classified as inpatient.

Hospitals have strong incentives to use observation. Recovery Audit Contractors (RACs) scrutinize inpatient admissions for medical necessity, and penalties for inappropriate inpatient classification can be severe—hospitals may have to repay the entire Medicare payment. Observation status, by contrast, is rarely audited. As a result, hospitals have shifted thousands of short-stay patients from inpatient to observation, a trend that accelerated after the Centers for Medicare & Medicaid Services (CMS) introduced the "two-midnight rule" in 2013, which presumed that stays shorter than two midnights should be observation unless the physician documents compelling reasons for inpatient admission. This rule was intended to limit observation by creating a clear threshold for inpatient admission. Instead, it gave hospitals a target: keep stays under two midnights as observation, and only admit patients who will stay longer. CMS data show that observation stays rose by roughly 70% between 2006 and 2016, while inpatient stays for the same conditions fell. A 2020 report from the Office of Inspector General found that 15% of observation stays exceeded 48 hours, and 5% lasted more than 72 hours. Some patients spend three or four days in a hospital bed, receiving the same nursing care, the same meals, and the same monitoring as inpatients, yet they are classified as outpatients. The distinction is invisible to the patient until the bill arrives—or until they need to enter a skilled nursing facility and discover that their three-day hospital stay does not qualify.

The result is a system where identical clinical presentations lead to different billing classifications based on hospital policy, physician documentation habits, and the timing of utilization review decisions—not on evidence-based risk stratification. A 2019 study in JAMA Internal Medicine found that among Medicare beneficiaries with chest pain, those treated at hospitals with high observation rates had no better outcomes than those at hospitals with low observation rates, but they faced significantly higher out-of-pocket costs.

How Observation Became a Billing Loophole

Observation status originated in the 1990s as a way to cover short stays for patients who needed monitoring but not full inpatient care. For example, a patient presenting with a transient ischemic attack (TIA)—a temporary blockage of blood flow to the brain that resolves within minutes to hours—might be observed for a few hours, undergo imaging, and then be discharged if no stroke is found. Similarly, a patient with a mild allergic reaction might be observed for several hours after treatment to ensure symptoms do not recur. The original intent was that observation would last less than 24 hours and would be used only when the diagnosis was genuinely uncertain.

Over time, the definition expanded. Hospitals began placing patients with clearly defined conditions, such as acute coronary syndrome, under observation for days at a time. The financial logic was simple: observation stays are reimbursed under Medicare Part B, which pays less than Part A inpatient rates but carries far lower audit risk. A hospital that admits a patient with chest pain for 24 hours and then discharges them might face a RAC audit demanding repayment if the medical record does not justify inpatient status. By classifying the stay as observation, the hospital avoids that risk entirely.

The two-midnight rule, implemented in 2013, attempted to curb this practice by establishing a presumption that inpatient admission is appropriate only if the physician expects the patient to require at least two midnights of hospital care. Stays shorter than two midnights should be observation, unless the physician documents a specific reason—such as a complex procedure or a high-risk condition—that justifies a shorter inpatient stay. But the rule had an unintended effect: it gave hospitals a bright-line target. Many began systematically classifying all stays under two midnights as observation, regardless of clinical nuance.

CMS has revised the rule multiple times, adding exceptions for complex cases and allowing inpatient admission for stays as short as one midnight if the physician documents a specific reason. But the underlying incentive structure remains unchanged: observation is safer for hospitals from an audit perspective, so it is used more often.

The Clinical Trap: What Evidence Says vs. What Hospitals Do

Clinical guidelines for chest pain evaluation have evolved significantly over the past decade. The HEART score—which incorporates history, ECG, age, risk factors, and troponin—can reliably identify patients at low risk for major adverse cardiac events within 30 days. Patients with a HEART score of 0–3 have a less than 2% risk of death, myocardial infarction, or revascularization. For these patients, guidelines recommend discharge with outpatient follow-up, not hospital admission or prolonged observation.

Yet a 2021 study in Circulation: Cardiovascular Quality and Outcomes found that 40% of low-risk chest pain patients in US emergency departments were still admitted or placed under observation. The reasons cited included physician discomfort with discharging patients without a stress test, lack of access to timely outpatient follow-up, and hospital protocols that mandate a period of monitoring regardless of risk score. The evidence suggests that observation does not improve outcomes for these patients. A randomized trial comparing observation to immediate discharge in low-risk chest pain patients would be difficult to conduct because of ethical concerns about withholding monitoring, but observational studies have consistently shown no difference in 30-day cardiac event rates between low-risk patients who are observed and those who are discharged.

What observation does reliably produce is more testing. Patients under observation are more likely to receive stress tests, coronary angiography, and advanced imaging—not because they need them, but because the hospital has time to perform them. A 2018 study in JAMA Internal Medicine found that observation stays for chest pain were associated with a 30% higher rate of cardiac catheterization compared with inpatient stays for the same risk profile, without any reduction in subsequent hospitalizations. The authors concluded that observation status may encourage a "test-to-discharge" mentality that drives up costs without improving care.

The gap between evidence and practice is partly a product of defensive medicine. Emergency physicians worry about missing a rare cardiac event and facing a malpractice suit. Observation feels safer than discharge, even when the evidence says otherwise. But observation is not a safety net—it is a billing category. The clinical care a patient receives in an observation unit is often identical to what they would receive on a hospital ward. The difference is entirely administrative.

Patient Stories: A $9,000 Difference for the Same Diagnosis

Consider two Medicare beneficiaries, both 72 years old, who present to different hospitals with syncope and a troponin of 0.04 ng/mL—just above the normal range. At Hospital A, the physician documents a concern for acute coronary syndrome and admits the patient as an inpatient. The patient stays 24 hours, has a negative stress test, and is discharged. The hospital bills Medicare Part A, and the patient owes the inpatient deductible of $1,600. The hospital stay counts toward the three-day requirement for skilled nursing coverage if needed.

At Hospital B, the same presentation is classified as observation. The patient stays 30 hours, undergoes the same testing, and is discharged. The hospital bills Medicare Part B. The patient receives separate bills for the emergency department visit, the observation services, the laboratory tests, and the stress test. The total patient responsibility, after Medicare pays 80%, comes to roughly $2,800. And if the patient falls at home a week later and needs skilled nursing, those 30 hours do not count toward the three-day inpatient requirement. The patient would have to pay out of pocket for the nursing home stay, which can easily exceed $10,000 for a week.

Private insurers often mirror Medicare's classification. A 2022 analysis by the Kaiser Family Foundation found that nearly all large employer plans use the same observation vs. inpatient distinction as Medicare, and many apply higher cost-sharing for observation services. Some insurers have begun to cover observation stays under the inpatient benefit, but this is not universal. Patients with high-deductible health plans are especially vulnerable: an observation stay can exhaust their entire deductible, leaving them with thousands of dollars in out-of-pocket costs for a condition that, in many cases, could have been managed in an outpatient clinic.

Consumer Reports documented cases of observation stays lasting 72 hours or more, with patients receiving bills for $9,000 or more after insurance. For instance, a composite case: a 68-year-old woman with chest pain was kept under observation for three days while her physicians ruled out a heart attack. She later received a bill for $8,700—her 20% coinsurance on the hospital's $43,500 charge. Had she been admitted as an inpatient, her out-of-pocket maximum would have capped her costs at $1,600. Another composite case: a 55-year-old man with atypical chest pain and a low HEART score was observed for 48 hours, underwent a stress test that was normal, and was billed $5,200 after insurance. His inpatient counterpart at another hospital paid only the $1,600 deductible.

These stories are not rare. A 2023 report from the National Academy of Medicine estimated that more than 1.5 million Medicare beneficiaries are placed under observation each year for cardiac symptoms alone. For many, the financial consequences extend beyond the hospital bill. Patients who are discharged from observation and later require skilled nursing—for example, after a fall or a stroke—face the full cost of that care because their observation days do not count toward Medicare's three-day qualifying stay. The out-of-pocket cost for a typical skilled nursing stay can range from $8,000 to $15,000 per month, depending on the facility and location.

Private insurers also vary widely in how they handle observation stays. Some plans, particularly those offered by large employers, have negotiated to cover observation stays under the inpatient benefit, but many still apply outpatient cost-sharing. A 2022 analysis by the Kaiser Family Foundation found that among employer-sponsored plans, roughly 60% applied the same observation vs. inpatient distinction as Medicare, while 30% covered observation under inpatient benefits, and 10% had no clear policy. This patchwork means that a patient's financial exposure depends not only on the hospital's classification but also on the specifics of their insurance plan.

Why Your Doctor Can't Fix This at the Bedside

Most emergency physicians have little control over whether a patient is classified as observation or inpatient. At many hospitals, the decision is made by utilization review nurses or case managers who review the patient's chart hours after the physician has written the admission order. These reviewers apply standardized criteria—often the InterQual or MCG (Milliman Care Guidelines) criteria—to determine whether the patient meets medical necessity for inpatient status. The physician's clinical judgment is secondary to these algorithms.

Clinical documentation improvement (CDI) teams further complicate the picture. These teams, whose compensation is often tied to hospital revenue, encourage physicians to document specific phrases—such as "acute hypoxic respiratory failure" instead of "shortness of breath"—to justify higher-paying inpatient codes. But for short stays, CDI teams often push for observation because it carries less audit risk. A physician who wants to admit a chest pain patient as an inpatient may be overruled by a CDI specialist who notes that the patient's HEART score is low and that the two-midnight rule would not be satisfied.

Malpractice concerns also drive defensive admission, regardless of billing status. A physician who discharges a low-risk chest pain patient from the emergency department faces a small but nonzero risk that the patient will have a heart attack at home. The legal system does not distinguish between observation and discharge—if the patient dies, the physician can be sued either way. Observation feels like a middle ground: the patient is monitored, but the physician is not committing to an inpatient admission that might be audited. This creates a perverse incentive to use observation for patients who could safely go home.

Hospital revenue cycle software now includes predictive models that flag patients with low expected reimbursement or high audit risk for observation status. These models are trained on historical claims data and are opaque to clinicians. A physician may write orders for inpatient admission, only to find that the hospital's billing system has automatically reclassified the stay as observation based on the patient's diagnosis codes and length-of-stay predictions. The physician has no practical way to override this reclassification.

Regulatory Patches That Haven't Worked

Congress has attempted to address observation status multiple times. The Notice of Observation Treatment and Implication for Care Eligibility (NOTICE) Act, passed in 2016, required hospitals to inform Medicare beneficiaries in writing if they were placed under observation for more than 24 hours. The notification must explain that observation status does not count toward the three-day inpatient requirement for skilled nursing coverage. But studies have shown that these notifications are often buried in admission paperwork, written in confusing language, or given to patients who are too ill to understand them. A 2019 survey found that only 30% of patients who received a NOTICE Act notification recalled being told about the implications for nursing home coverage.

Bipartisan bills in Congress have sought to count observation time toward the three-day inpatient requirement for skilled nursing coverage. The Improving Access to Medicare Coverage Act, introduced repeatedly since 2011, would require that all time spent in the hospital—whether inpatient or observation—count toward the qualifying stay. The bill has never passed, largely because of cost: the Congressional Budget Office estimated it would increase Medicare spending by roughly $10 billion over ten years, as more beneficiaries would qualify for nursing home coverage. Private insurers have opposed similar measures, arguing that they would increase premiums.

CMS has not defined a maximum duration for observation stays. The agency has issued guidance stating that observation should not exceed 48 hours in most cases, but this is not a binding rule. Hospitals that keep patients under observation for 72 hours or more face no penalty. A 2020 report from the Government Accountability Office recommended that CMS establish a specific time limit, but the agency has not acted. As a result, observation status remains a loophole that can trap patients for days at a time.

What a Clinician Can Actually Do Right Now

While the systemic issues are daunting, individual clinicians can take steps to protect their patients. The first is to understand their hospital's observation criteria. Many hospitals have written guidelines that specify which conditions and risk scores should trigger observation vs. inpatient status. Asking the CDI team for a copy of these criteria—and for the InterQual or MCG thresholds—can help physicians anticipate how their documentation will be interpreted.

Shared decision-making tools like the HEART pathway can empower patients to choose discharge over observation when the risk is low. A 2020 study in Academic Emergency Medicine found that when emergency physicians used a shared decision-making tool with low-risk chest pain patients, the rate of observation stays dropped by 25%, and patient satisfaction increased. The key is to present the evidence clearly: the risk of a cardiac event in the next 30 days is less than 2%, and observation does not reduce that risk.

Documentation matters. Physicians who believe a patient requires inpatient admission should document the medical necessity explicitly, referencing clinical factors such as hemodynamic instability, high-risk ECG findings, or a HEART score above 3. The two-midnight rule allows inpatient admission for stays shorter than two midnights if the physician documents a compelling reason. Using phrases like "high-risk unstable angina" or "concern for acute coronary syndrome with dynamic ECG changes" can support inpatient classification. Conversely, documenting "chest pain, low risk" may steer the case toward observation.

Clinicians can also advocate for observation-only clinical pathways that aim for discharge within 24 hours. Some hospitals have implemented accelerated diagnostic protocols that use serial troponin testing at 0 and 2 hours, combined with a HEART score, to identify patients who can be safely discharged without prolonged monitoring. These pathways reduce observation stays, lower costs, and improve patient flow. A 2022 study in Annals of Emergency Medicine found that an accelerated protocol reduced median observation time from 26 hours to 14 hours without increasing adverse events.

Finally, physicians can support legislation that aligns billing with clinical risk. The Improving Access to Medicare Coverage Act has been endorsed by the American College of Emergency Physicians, the American College of Physicians, and the American Hospital Association. Writing to representatives, participating in advocacy days, and educating patients about the issue can build political will for reform. Until the law changes, observation status will remain a trap for patients who trust that a hospital stay will be covered.

Conclusion: A System That Needs Realignment

The observation status loophole reveals a fundamental misalignment between clinical care and billing in US healthcare. Patients with identical conditions can face dramatically different financial outcomes based on administrative decisions made far from the bedside. The evidence shows that observation does not improve outcomes for low-risk cardiac patients, yet it persists because it protects hospitals from audit risk and allows them to avoid the costs of inpatient admission. The result is a system that penalizes the very patients it is meant to serve—those who seek care for chest pain and end up with bills that can exceed $10,000, plus the risk of uncovered nursing home stays.

Until Congress acts to count observation time toward the three-day qualifying stay for skilled nursing, and until CMS enforces meaningful limits on observation duration, patients will continue to fall through this gap. Clinicians can fight back with better documentation, shared decision-making, and advocacy, but the problem is structural. The observation status loophole is not a bug in the system—it is a feature of a billing system designed to minimize hospital liability, not to maximize patient well-being. Recognizing this is the first step toward demanding change.

This article is for informational purposes only and does not constitute professional medical or financial advice. Patients should consult their healthcare provider and insurance plan for guidance specific to their situation.

Recommend Posts
Health

Rural Kenyan Mothers Lose Newborns to Birth Asphyxia While Resuscitation Training Gathers Dust

By Raphael Andriamanjato/Jul 10, 2026

In rural Kenya, birth asphyxia kills 40% of newborns despite available resuscitation kits. Training gaps, stock-outs, and weak supervision leave mothers grieving preventable deaths.
Health

Preterm Birth Prevention With Progesterone Reaches Clinics While Cervical Length Screening Stays Sporadic

By Min Park/Jul 10, 2026

Progesterone therapy reduces preterm birth risk by about 45% in women with a short cervix, yet cervical length screening remains sporadic, especially in low-resource settings. This article explores the mechanisms, evidence, and implementation gaps.
Health

London NHS Psychiatrist Caseload Reaches 600 While Durban Clinic Sees One Doctor per 50,000

By Esther Okello/Jul 10, 2026

London NHS psychiatrists carry 600 patients while Durban clinics have one doctor per 50,000. Both systems face burnout, rationed care, and training leaks. A look at what caseload does to care.
Health

UK Prior Authorization Delays Biologic Therapy While Step‑Therapy Failures Go Unreported

By Min Park/Jul 10, 2026

UK prior authorization requirements for biologics cause delays of 8–12 weeks, with step-therapy failures rarely tracked. This gap leads to clinical deterioration and avoidable hospitalizations.
Health

UK Antidepressant Prescriptions Rise While Therapy Access Poses an Unresolved Controversy

By Esther Okello/Jul 10, 2026

Antidepressant prescribing in the UK has risen sharply, yet therapy access remains uneven. Experts disagree on first-line treatment, while GP constraints and workforce shortages deepen the divide.
Health

Dar es Salaam Clinic Offers Free Asthma Inhalers While Spirometry Machines Gather Dust

By Esther Okello/Jul 10, 2026

In Dar es Salaam, clinics distribute free asthma inhalers while spirometry machines sit unused. Experts debate whether symptom-based care is enough for respiratory diagnosis in low-resource settings.
Health

South African Type‑2 Diabetes Patients Get Metformin While Insulin Access Lags Behind

By Raphael Andriamanjato/Jul 10, 2026

In South Africa, metformin remains the default for type-2 diabetes while insulin is often delayed until complications arise. This article examines the controversy over early insulin use and the barriers to access.
Health

Rajasthan Public Hospitals Offer Free Radiotherapy While Linear Accelerator Downtime Reaches Six Months

By Elena Vargas/Jul 10, 2026

Rajasthan offers free radiotherapy but linear accelerators sit idle for months. Cervical cancer patients bear the burden as downtime exceeds six months in some districts.
Health

Lagos Public Clinics Stock Malaria RDTs While Microscopy Malaria Diagnosis Rates Stall

By Elena Vargas/Jul 10, 2026

Lagos public clinics are well-stocked with rapid diagnostic tests for malaria, yet microscopy diagnosis rates remain low. Why clinicians bypass guidelines and what can be done.
Health

Kisumu Maternity Ward Offers Free Oxytocin While Delivery Room Thermometer Gaps Risk Neonatal Hypothermia

By Esther Okello/Jul 10, 2026

In Kisumu, Kenya, free oxytocin saves lives, but delivery rooms lack thermometers. Neonatal hypothermia remains a hidden killer, with simple solutions overlooked.
Health

US Medicare Caps Antibiotic Reimbursement While Resistant Gonorrhea Cases Double

By Raphael Andriamanjato/Jul 10, 2026

US Medicare's low antibiotic reimbursement discourages clinics from stocking effective gonorrhea treatments, even as resistant cases double. Experts warn of untreatable strains without policy change.
Health

Mumbai Textile Workers Develop COPD While Public Spirometry Tests Cost a Week's Pay

By Esther Okello/Jul 10, 2026

For Mumbai's powerloom workers, a spirometry test costs ₹500–700 while daily wages are ₹300–400. Many skip diagnosis until breathlessness is severe, missing the window for early treatment.
Health

US Emergency Departments Bill Cardiac Observation as Inpatient While Observation Status Denies Coverage

By Raphael Andriamanjato/Jul 10, 2026

Two patients with identical chest pain can face vastly different bills depending on whether a hospital classifies their stay as observation or inpatient. This gap in US healthcare billing affects coverage for nursing home stays and out-of-pocket costs.
Health

Prior Authorization for US CT Angiography Denies 1 in 8 Scans While Cardiac Deaths Rise

By Elena Vargas/Jul 10, 2026

One in eight CT angiography scans is denied upfront by US insurers, even as cardiac deaths rise. This article examines the evidence gap, patient impact, and policy options.
Health

Rajasthan Public Clinics Stock Metformin While Insulin Refrigeration Gaps Worsen HbA1c

By Min Park/Jul 10, 2026

In Rajasthan, public clinics reliably stock metformin, but insulin refrigeration gaps in rural areas lead to poor HbA1c control. Solar fridges and heat-stable insulins offer hope, but scale-up is slow.
Health

South African Public Hospitals Stock Antiretrovirals While CD4 Machine Downtime Reaches Five Months

By Min Park/Jul 10, 2026

Explore the biology of depression, why antidepressants often fail, and how ketamine, inflammation, and access gaps shape treatment outcomes.
Health

Rural Kenyan Nurse Vacancies Stay Unfilled While Urban Private Clinics Hire Retired Staff

By Raphael Andriamanjato/Jul 10, 2026

Kenya's rural public facilities face chronic nurse vacancies exceeding 50% in some counties, while urban private clinics hire retired nurses at higher pay, widening the urban-rural staffing divide.
Health

Hospitalist Visit Caps Leave One in Five US Inpatients Without a Physician Round

By Raphael Andriamanjato/Jul 10, 2026

Hospitalist visit caps leave one in five US inpatients without a daily physician round. Burnout, staffing shortages, and lack of backup systems drive the problem, affecting patient safety and satisfaction.
Health

UK Postnatal Chlamydia Screening Lapses Miss Up to Half of Silent Infections

By Raphael Andriamanjato/Jul 10, 2026

Up to half of postnatal chlamydia cases go undetected in the UK. Evidence shows 3–5% prevalence, yet routine screening stops after birth. GPs face time pressure, unclear guidance, and focus on the baby. Neonatal risks and cost-effectiveness call for change.
Health

Huye District Diabetic Patients Receive Metformin While HbA1c Testing Waits Six Months

By Min Park/Jul 10, 2026

In Rwanda's Huye District, patients get metformin but HbA1c tests face six-month waits. This article explains the biology of glycation, supply chain barriers, and potential solutions like point-of-care devices.